Epithalon: Telomeres, the Pineal Gland and Longevity
Epithalon (also written Epitalon or Epithalamin) is a synthetic tetrapeptide —sequence Ala-Glu-Asp-Gly (AEDG)— modeled on epithalamin, a peptide extract of the pineal gland. It is one of the most studied "peptide bioregulators" in Russian aging research. We review its most-cited mechanism (telomerase and telomeres), its effect on melatonin and circadian rhythm, the longevity models, and why the evidence should be read with caution.
What Epithalon is
Epithalon is a very short synthetic peptide: a tetrapeptide of four amino acids with the sequence Ala-Glu-Asp-Gly (AEDG). It was designed as the active fraction of epithalamin, a peptide extract obtained from the pineal gland. That is why it appears under several names in the literature: Epithalon, Epitalon and Epithalamin.
It was developed in Russia by researcher Vladimir Khavinson, within a class he calls "peptide bioregulators": short peptides that, on his hypothesis, would act as regulatory signals for gene expression in specific tissues. Epithalon is the molecule associated with the pineal axis of that research program.
It is important to frame it correctly: Epithalon is an investigational compound. Much of the data comes from Khavinson's own group and long-term human evidence is limited, so its effects are described here as reported or derived from preliminary studies, not as established clinical facts.
Telomerase and telomeres
Epithalon's most-cited mechanism is its effect on telomerase. Telomeres are the "caps" of repetitive DNA at the ends of chromosomes; they shorten with each cell division, and their erosion is one of the classic markers of cellular aging. Telomerase is the enzyme that can rebuild those sequences.
In cell culture, several works from Khavinson's group have reported that Epithalon induces telomerase activity and is associated with telomere lengthening in human fibroblasts, along with a greater number of cell divisions before senescence. Preliminary human studies have also been published suggesting effects on aging-associated markers.
Caution here is essential. These findings:
- Come largely from a single research group, with limited independent replication.
- Are based mostly on cell culture and animal models; extrapolation to the whole human organism is not established.
- Do not amount to a claim of "extending lifespan" in humans — telomerase activation is a plausible mechanism, not a demonstrated clinical outcome.
Pineal gland, melatonin and circadian rhythm
Given its pineal origin, Epithalon's second line of research is circadian regulation. The pineal gland produces melatonin following the light-dark cycle, and the amplitude of that rhythm tends to flatten with age.
Studies in animal models and some work in elderly humans have reported that Epithalon helps restore the rhythm of melatonin secretion, recovering a more pronounced nocturnal pattern. The hypothesis is that, by acting on pineal function, it normalizes circadian signals that would otherwise deteriorate with aging — which would connect sleep, hormonal rhythm and other processes dependent on the biological clock.
Again, this is best read as a coherent line of research consistent with the peptide's origin, not as a confirmed clinical effect.
Antioxidant and longevity models
A third group of findings describes antioxidant effects: in preclinical models Epithalon has been reported to reduce markers of oxidative stress and lipid peroxidation, a mechanism frequently associated with the oxidative-damage theory of aging.
In animal longevity models (rodents), Khavinson's group reported increases in mean life expectancy and a reduction in spontaneous tumor incidence in some experiments. These results have received the most media attention, but they are also the ones that demand the most prudence:
- Life extension in rodents does not automatically translate to humans.
- Replication outside the original group is scarce.
- There are no large-scale, controlled, long-term clinical trials confirming a longevity benefit in people.
Taken together, Epithalon is a compound that is mechanistically interesting —telomeres, pineal rhythm, antioxidation— but whose longevity promise remains, today, a hypothesis under investigation.
Epithalon and Pinealon
Epithalon is part of a family of short peptide bioregulators described by Khavinson's group, where each peptide is associated with a tissue or organ. It is useful to distinguish it from its closest "relative" in practical use, Pinealon:
| Peptide | Sequence | Reported axis / focus |
|---|---|---|
| Epithalon | Ala-Glu-Asp-Gly (AEDG) | Pineal · telomeres · melatonin rhythm · longevity |
| Pinealon | Glu-Asp-Arg (EDR) | Brain · cognition · neuronal protection against stress |
Both emerge from the same research school, but they target different goals: Epithalon is associated with the pineal/telomere axis and the regulation of aging, while Pinealon is studied more for its neuroprotective and cognitive effects. Some research protocols combine them, precisely because of their reported complementarity.
Reconstitution
Epithalon is offered as a lyophilized powder in a 50 mg vial and is reconstituted with your own bacteriostatic water at the concentration you define for your work.
Calculation example (50 mg vial + 5 mL bacteriostatic water = 10 mg/mL): to research 5 mg → 0.5 mL → 50 units on a U100 syringe. If you prefer a more dilute concentration, 50 mg + 10 mL = 5 mg/mL, and then 5 mg → 1 mL → 100 units.
After reconstitution, refrigerate (2–8 °C) and protect from light. For custom calculations use the reconstitution calculator or see the complete reconstitution guide.
Epithalon at Renova
Epithalon is available in a 50 mg presentation at $229, as lyophilized powder.
Our material is manufactured in a cGMP-compliant US lab that we work with directly, with a Certificate of Analysis (COA) by HPLC and mass spectrometry.
Related products
⚠ For research use only. Not medical advice. Epithalon is an investigational compound, not approved for human use. Much of the evidence is preliminary and comes from a limited number of research groups; this information describes reported findings for educational and scientific research purposes.